Scarica l'app Stockscreener
7.10
0.05%
0.0165
Precedente Chiudi:
$7.1165
Aprire:
$7.2775
Volume 24 ore:
17,452
Relative Volume:
0.07
Capitalizzazione di mercato:
$3.33M
Reddito:
-
Utile/perdita netta:
$-8.28M
Rapporto P/E:
-1.277
EPS:
-5.56
Flusso di cassa netto:
$-7.99M
1 W Prestazione:
+25.57%
1M Prestazione:
-15.87%
6M Prestazione:
-76.86%
1 anno Prestazione:
-68.09%
Intervallo 1D:
$7.05
$7.6616
Intervallo di 1 settimana:
$5.49
$7.6616
Portata 52W:
$5.01
$54.95
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Nome
Quoin Pharmaceuticals Ltd Adr
Settore
Industria
Telefono
97299741444
Indirizzo
23 HATA'AS STREET, KFAR SABA
Confronta QNRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
7.10 | 3.33M | 0 | -8.28M | -7.99M | -5.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
494.76 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
612.15 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
617.17 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.69 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
251.34 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Quoin Pharmaceuticals Ltd Adr Borsa (QNRX) Ultime notizie
Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series - TipRanks
QNRX Stock Plummets to 52-Week Low of $0.17 Amid Market Struggles - Investing.com India
QNRX stock’s current quarter earnings estimates: What analysts predict? - uspostnews.com
Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com
Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements By Investing.com - Investing.com South Africa
Quoin Pharmaceuticals announces ADS ratio change to meet Nasdaq requirements - Investing.com
Quoin Pharmaceuticals reports positive clinical data for rare disease treatment - Investing.com India
Quoin Pharmaceuticals reports positive clinical data for rare disease treatment By Investing.com - Investing.com South Africa
What Is Going On With Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX)? - stocksregister.com
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles By Investing.com - Investing.com South Africa
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles - Investing.com India
Quoin seeks patent for skin disease treatment QRX003 By Investing.com - Investing.com South Africa
Quoin seeks patent for skin disease treatment QRX003 - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa
NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater
Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com India
Stock Performance Spotlight: Quoin Pharmaceuticals Ltd ADR (QNRX) Ends the Day at 0.31, Down by -2.06 - The Dwinnex
Is Energy Services of America Corp (NASDAQ: ESOA) Poised For Further Gains At A 45.82% Distance From The Low? - Marketing Sentinel
Should You Expect Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) To Recover From Its 9.68% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel
BTC Digital Ltd (NASDAQ: BTCT): Can A Stock Be Up 21.97% YTD, And Still Be A Loser - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Aurora Mobile Ltd ADR (NASDAQ: JG) Stock Gained 83.28% Over A Month – Any Room To Run? - Marketing Sentinel
Now Is The Time To Build A Position In Atyr Pharma Inc (NASDAQ:ATYR) - Marketing Sentinel
Berry Global Group Inc [BERY] Records 200-Day SMA of $64.89 - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
INVZ Shares Experience Surge in Value - Knox Daily
Jefferies Financial Group Inc [JEF] Shares Rise 1.55 % on Thursday - Knox Daily
DHT Holdings Inc [DHT] Shares Jump Approximately 9.62% Over the Year - Knox Daily
Now Is The Time To Build A Position In American Battery Technology Company (NASDAQ:ABAT) - Marketing Sentinel
After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel
Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel
Orangekloud Technology Inc (NASDAQ: ORKT) Up 58.11% From 52-Week Low; YTD Falls -50.99% – Here’s What To Do Now – Marketing Sentinel - Marketing Sentinel
Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
PDD Holdings Inc ADR (NASDAQ: PDD): How To Buy And When To Buy And Its Performance & Trends - Marketing Sentinel
Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com India
Understanding QNRX’s financial ratios: A beginner’s guide - US Post News
An Overview of Castellum Inc (AMEX: CTM)’s Stock Performance and Outlook - Marketing Sentinel
Why Should You Invest In Castellum Inc (AMEX: CTM)? - Marketing Sentinel
FTAI Infrastructure Inc (NASDAQ:FIP) Shares Dropped -1.13% In A Week. Can It Continue Rising? - Marketing Sentinel
Capricor Therapeutics Inc (NASDAQ:CAPR) Decline -1.05%, More Rally Possible - Marketing Sentinel
Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - MSN
AST SpaceMobile Inc (ASTS) Investors Will See A Big Return Again - Marketing Sentinel
Why Acquire Shares Of Castellum Inc (CTM)? - Marketing Sentinel
Syros Pharmaceuticals Inc (NASDAQ: SYRS) Fell -2280.95%, Predicting What To Expect In The Near Future - Marketing Sentinel
Sobr Safe Inc (NASDAQ: SOBR) Fall -93.95% In Six Months, Here’s What We Should Expect Now - Marketing Sentinel
Future Prospects And Stock Pricing Of DatChat Inc (NASDAQ: DATS) - Marketing Sentinel
Quoin Pharmaceuticals Ltd Adr Azioni (QNRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):